1. Deletion of the extracellular matrix glycoprotein ADAMTSL3 increases pro-fibrotic signalling and exacerbates heart failure in mice. (3rd October 2022) Authors: Rypdal, K; Melleby, A O; Robinson, E L; Palmero, S; Seifert, D; Martin, D; Andreassen, K; Dahl, C P; Sjaastad, I; Toennessen, T; Stokke, M; Heymans, S; Christensen, G; Apte, S; Lunde, I G Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibition of phosphodiesterase‐3 by levosimendan is sufficient to account for its inotropic effect in failing human heart. (December 2014) Authors: Ørstavik, Ø; Ata, S H; Riise, J; Dahl, C P; Andersen, G Ø; Levy, F O; Skomedal, T; Osnes, J‐B; Qvigstad, E Journal: British journal of pharmacology Issue: Volume 171:Number 23(2014:Dec.) Page Start: 5169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1744Hypothermia-induced diastolic dysfunction in ventricular trabeculae from human failing explanted hearts is caused by elongated contraction-relaxation cycle time and is worsened by increased heart rate. (28th August 2018) Authors: Krobert, K; Hiis, H G; Cosson, M V; Dahl, C P; Fiane, A E; Levy, F O; Andersen, G Ø Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗